GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)

Symbol: IRD on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,015,726	504,983	+36,046	+7.7%	$2.01	Q4 2025
30 Sep 2025	0%	+0%	$773,844	468,937	+113,260	+32%	$1.65	Q3 2025
30 Jun 2025	0%	0%	$335,135	355,677	+2,268	+0.64%	$0.94	Q2 2025
31 Mar 2025	0%	+0%	$347,042	353,409	+39,425		$0.98	Q1 2025
31 Dec 2024	0%	+0%	$373,720	313,984	+41,703	+15%	$1.19	Q4 2024
30 Sep 2024	0%	+0%	$356,757	272,281	+6,427	+2.4%	$1.31	Q3 2024
30 Jun 2024	0%	+0%	$406,842	265,854	+31,456	+13%	$1.53	Q2 2024
31 Mar 2024	0%	+0%	$471,249	234,398	+15,285	+7%	$2.01	Q1 2024
31 Dec 2023	0%	0%	$659,679	219,113	0		$3.01	Q4 2023
30 Sep 2023	0%	+0%	$734,212	219,113	+25,064	+13%	$3.35	Q3 2023
30 Jun 2023	0%	+0%	$842,172	194,049	+12,679	+7%	$4.34	Q2 2023
31 Mar 2023	0%	+0%	$680,137	181,370	+8,303	+4.8%	$3.75	Q1 2023
31 Dec 2022	0%	+0%	$610,000	173,067	+21,498	+14%	$3.52	Q4 2022
30 Sep 2022	0%	+0%	$304,000	151,569	+4,110	+2.8%	$2.01	Q3 2022
30 Jun 2022	0%	+0%	$283,000	147,459	+17,535	+13%	$1.92	Q2 2022
31 Mar 2022	0%	+0%	$420,000	129,924	+38,856	+43%	$3.23	Q1 2022
31 Dec 2021	0%	+0%	$339,000	91,068	+12,145	+15%	$3.72	Q4 2021
30 Sep 2021	0%	+0%	$406,000	78,923	+53,329	+208%	$5.14	Q3 2021
30 Jun 2021	0%	+0%	$135,000	25,594	+14,294	+126%	$5.27	Q2 2021
31 Mar 2021	0%	+0%	$65,000	11,300	+11,300	NEW	$5.75	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.